Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
34.63
+0.07 (0.20%)
At close: Jun 12, 2026, 4:00 PM EDT
34.55
-0.08 (-0.23%)
After-hours: Jun 12, 2026, 7:45 PM EDT
Teva Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $42 | Buy | Reiterates | $42 | +21.28% | Jun 1, 2026 |
| Jefferies | Jefferies | Buy Maintains $40 | Buy | Maintains | $40 | +15.51% | May 27, 2026 |
| Barclays | Barclays | Buy Maintains $38 → $40 | Buy | Maintains | $38 → $40 | +15.51% | May 6, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +44.38% | Apr 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +15.51% | Apr 30, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $40 | Buy | Maintains | $40 | +15.51% | Apr 30, 2026 |
| UBS | UBS | Buy Reiterates $36 → $42 | Buy | Reiterates | $36 → $42 | +21.28% | Apr 30, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $40 | Buy | Reiterates | $40 | +15.51% | Apr 30, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.